A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: A randomized open-label clinical trial

Clinical and Experimental Dermatology

Volumn 35, Issue 3, 2010, Pages 251-256

  Koca, R ^a   Altinyazar, H C ^a   Ankarali, H ^b   Muhtar, S ^a   Tekin, N S ^a   Cinar S ^a  

^a Department of Dermatology ^*  (United Kingdom)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; PIMECROLIMUS; ROZA; UNCLASSIFIED DRUG;

ADULT; APPLICATION SITE PRURITUS; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; FACE ERYTHEMA; FEMALE; HUMAN; MALE; MORNING DOSAGE; PAPULOPUSTULAR ROSACEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SCORING SYSTEM; SKIN MANIFESTATION; STINGING SENSATION; TELANGIECTASIA; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADULT; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS; DERMATOLOGIC AGENTS; EMOLLIENTS; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; ROSACEA; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77749344621     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03427.x     Document Type: Article

References (23)

1. Powell FC. Clinical practice. Rosacea. N Engl J Med 2005 352 : 793 803.
2. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989 69 : 419 423.
3. Wilkin J, Dahl M, Detmar M et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002 46 : 584 587.
4. Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol 1994 130 : 359 362.
5. Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett 2007 12 : 1 5.
6. van Zuuren EJ, Gupta AK, Gover MD et al. Systematic review of rosacea treatments. J Am Acad Dermatol 2007 56 : 107 115.
7. Dahl MV, Katz HI, Krueger GG et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998 134 : 679 683.
8. Liu RH, Smith MK, Basta SA, Farmer ER. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol 2006 142 : 1047 1052.
9. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994 130 : 319 324.
10. Gupta AK, Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003 17 : 493 503.
11. Weissenbacher S, Merkl J, Hildebrandt B et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol 2007 156 : 728 732.
12. Cunha PR, Rossi AB. Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. Acta Derm Venereol 2006 86 : 71 2.
13. Crawford KM, Russ B, Bostrom P. Pimecrolimus for treatment of acne rosacea. Skinmed 2005 4 : 147 150.
14. Chu CY. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Br J Dermatol 2005 152 : 396 399.
15. Chu CY. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol 2007 21 : 484 490.
16. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999 40 : 961 965.
17. McClellan KJ, Noble S. Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 2000 1 : 191 199.
18. Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol 1986 114 : 231 234. (Pubitemid 16131430)
19. Luger T, Van Leent EJ, Graeber M et al. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 2001 144 : 788 794.
20. El Sayed F, Ammoury A, Dhaybi R, Bazex J. Rosaceiform eruption to pimecrolimus. J Am Acad Dermatol 2006 54 : 548 550.
21. Gorman CR, White SW. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. Arch Dermatol 2005 141 : 1168.
22. Lubbe J, Stucky L, Saurat JH. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology 2003 207 : 204 205.
23. Yoon TY, Kim HJ, Kim MK. Pimecrolimus-induced rosacea-like demodicidosis. Int J Dermatol 2007 46 : 1103 1105.